Medicine – Scientific American

Blood tests that find malignancies before they spread could transform our approach to treatment…

The pandemic is no excuse to abandon chronic disease management and prevention

Despite conflicting data, the highly anticipated results will make the treatment a standard of care in the United States

April 30, 2020 — Heidi Ledford and Nature magazine

Amyloid, the leading target for dementia therapy, faces skepticism after drug failures

April 29, 2020 — Tanya Lewis

Candidates are speeding toward human trials

April 29, 2020 — Charles Schmidt

With politicians touting the potential benefits of malaria drugs to fight COVID-19, some people are turning away from clinical trials of other therapies

April 28, 2020 — Heidi Ledford and Nature magazine

Recent epidemics provide clues to ways the current crisis could stop

April 28, 2020 — Lydia Denworth

Compassionate use of experimental medicine needs to coexist with scientific rigor to help patients, researchers write in the journal Science

April 24, 2020 — Anna Kuchment

With no time to make treatments from scratch, researchers search for existing compounds that deflect harm

April 23, 2020 — Michael Waldholz

Support grows for a controversial ‘human challenge’ vaccine study—but no trial is yet planned

April 22, 2020 — Ewen Callaway and Nature magazine

Research into the brain’s protein-disposal systems, electrical activity and three other areas looks promising

April 22, 2020 — Kenneth S. Kosik

Many hospitalized victims are developing potentially lethal secondary coinfections such as bacterial pneumonia and sepsis

Numerous contenders—from a controversial malaria medication to treatments that regulate the immune system—are now in clinical trials

April 16, 2020 — Tanya Lewis

In mice, a test for lung cancer involves nanoprobes that recognize tumors and send reporter molecules into the urine for simple analysis.

April 15, 2020 — W. Wayt Gibbs

A new era for Alzheimer’s and journalism in the time of coronavirus 

April 14, 2020 — Curtis Brainard

Originally published in June 1954

April 13, 2020

Slated for human trials, EIDD-2801 could become the first pill for COVID-19

April 7, 2020 — Michael Waldholz

Originally published in June 1868

April 7, 2020

Fighting the disease is like trying to hit a moving target, evolutionarily speaking

From online journal clubs to “tweetorials” to conference updates, social media is changing the dissemination and discussion of biomedicine

April 1, 2020 — Nicole Wetsman and Nature Medicine

Source Article

Post navigation